JPH11279072A - Skin preparation for external use - Google Patents

Skin preparation for external use

Info

Publication number
JPH11279072A
JPH11279072A JP10100610A JP10061098A JPH11279072A JP H11279072 A JPH11279072 A JP H11279072A JP 10100610 A JP10100610 A JP 10100610A JP 10061098 A JP10061098 A JP 10061098A JP H11279072 A JPH11279072 A JP H11279072A
Authority
JP
Japan
Prior art keywords
skin
genus
lectin
eucheuma
external use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10100610A
Other languages
Japanese (ja)
Inventor
Tetsuya Sado
哲也 佐道
Hisao Namioka
日左雄 浪岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KAISO SHIGEN KENKYUSHO KK
Lion Corp
Original Assignee
KAISO SHIGEN KENKYUSHO KK
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KAISO SHIGEN KENKYUSHO KK, Lion Corp filed Critical KAISO SHIGEN KENKYUSHO KK
Priority to JP10100610A priority Critical patent/JPH11279072A/en
Publication of JPH11279072A publication Critical patent/JPH11279072A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a skin preparation for external use excellent in improvement of roughened skin, skin moisture-retaining effect and aging-preventing and improving effect of skin by making the preparation include a protein containing lectin of the genus Eucheuma or genus Kappaphycus as an active ingredient. SOLUTION: This skin preparation for external use contains a protein containing lectin of the genus Eucheuma or genus Kappaphycus obtained from seaweed [e.g. Eucheuma serra] belonging to the genus Eucheuma or the genus Kappaphycus as an active ingredient. A lectin having about 25,000 molecular weight by gel permeation method, about 29,000 molecular weight by SDS electrophoresis, p14.5 to 5.7 isoelectric point measured by polyacrylamide gel isoelectric point electrophoresis, not having sugar chain and having an amino acid sequence in N terminal region represented by the formula Gly-Arg-Tyr-Thr-Val-X-Asn-Gln- Trp-gly (X is Gln or Lys) is preferably used as the lectin of the genus Eucheuma or genus Kappaphycus and formulating amount of the lection is preferably used in an amount of 0.001-5 wt.% based on the objective preparation for external use.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、特に肌荒れ改善、
皮膚保湿効果及び皮膚の老化防止・改善効果に優れた皮
膚外用剤に関する。
[0001] The present invention relates to a method for improving skin roughness,
The present invention relates to an external preparation for skin having excellent skin moisturizing effects and skin aging prevention / improvement effects.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】近年、
乾燥による皮膚のバリアー機能の低下やアレルギー性疾
患により、皮膚トラブルが増加しており、荒れ肌改善、
皮膚保湿効果に優れた外用剤が強く求められている。そ
のため、皮膚の乾燥性疾患やアレルギー性疾患に対し、
皮膚のバリアー機能を高め、皮膚を健康に保つことを目
的として、グリチルレチン酸等の抗炎症剤や各種保湿剤
を用いる提案が多数なされているが、効果の点で十分と
は言えない。また、皮膚は老化に伴い、柔軟性・弾力性
の低下、しわの増加、乾燥して滑らかさのない荒れた肌
として認められるようになる。これら皮膚の老化をもた
らす因子として、細胞の内的要因、つまり遺伝的要因
と、もう一つは栄養、内分泌、ストレス、環境等の外的
要因が挙げられ、特に皮膚は、直接外界と接しており、
紫外線、乾燥、冷寒等に強く影響されることが知られて
いる。こうした老化症状の改善を目的に、α−トコフェ
ロール、α−ヒドロキシ酸、レチノール等の薬剤が提案
されているが、老化防止効果として十分でなかったり、
皮膚刺激等の問題がある。
2. Description of the Related Art In recent years,
Skin troubles are increasing due to decreased skin barrier function and allergic diseases due to drying, improving rough skin,
There is a strong demand for an external preparation having an excellent skin moisturizing effect. Therefore, for dryness and allergic diseases of the skin,
Many proposals have been made to use anti-inflammatory agents such as glycyrrhetinic acid and various moisturizing agents for the purpose of enhancing the barrier function of the skin and keeping the skin healthy, but they cannot be said to be sufficient in terms of effect. Further, as the skin ages, the skin becomes less perceived as having reduced flexibility and elasticity, increased wrinkles, and is dry and rough without rough skin. These factors that cause skin aging include internal factors of cells, that is, genetic factors, and other factors such as nutrition, endocrine, stress, and environmental factors. In particular, skin directly contacts the outside world. Yes,
It is known that it is strongly affected by ultraviolet rays, drying, cold and the like. For the purpose of improving such aging symptoms, drugs such as α-tocopherol, α-hydroxy acid, and retinol have been proposed, but are not sufficient as antiaging effects,
There are problems such as skin irritation.

【0003】従って、本発明は、上記問題のない優れた
肌荒れ改善、皮膚保湿効果及び皮膚の老化防止・改善効
果を有する皮膚外用剤を提供することを目的とする。
[0003] Accordingly, an object of the present invention is to provide an external preparation for skin having the above-mentioned problems, which is excellent in improving skin roughness, moisturizing the skin, and preventing and improving skin aging.

【0004】[0004]

【課題を解決するための手段及び発明の実施の形態】本
発明者らは、上記目的を達成するため鋭意検討を行った
結果、キリンサイ属レクチンを含むタンパク質、特にW
O95/18149に記載されているようなレクチン
が、肌荒れ改善、皮膚保湿、皮膚の老化防止及び改善に
優れた効果を与えることを見出し、本発明を完成するに
至った。
Means for Solving the Problems and Embodiments of the Invention The present inventors have conducted intensive studies in order to achieve the above object, and as a result, have found that proteins containing Kirinsai lectin, especially W
The lectin as described in O95 / 18149 has been found to provide excellent effects on improving skin roughness, moisturizing the skin, preventing and improving skin aging, and completed the present invention.

【0005】以下、本発明につき更に詳しく説明する
と、本発明の皮膚外用剤は、キリンサイ属レクチンを含
むタンパク質を有効成分として含有するものである。
Now, the present invention will be described in further detail. The external preparation for skin of the present invention contains a protein containing a Ginseng lectin as an active ingredient.

【0006】このキリンサイ属レクチンを含むタンパク
質は、キリンサイ属(Eucheuma属又はKapp
aphycus属)に属する海藻から得られるが、この
キリンサイ属に属する海藻としては、トゲキリンサイ
(E.serra)、ユーキュウマコットニー(E.c
ottonii)、カタメンキリンサイ(E.gela
tinae)及びアマクサキリンサイ(E.amaku
saensis)、E.denticulatum、
E.muricatum、E.cupresoiseu
m、E.spinosum、E.arnoldii、
E.alvarezii、E.striatum等のE
ucheuma属及びK.procrusteanu
m、K.cottonii、K.striatum、
K.alvarezii、K.arnoldii等のK
appaphycus属に属する海藻が挙げられる。レ
クチンの含有量や入手のし易さ等から判断し、好ましく
はトゲキリンサイ(E.serra)、ユーキュウマコ
ットニー(E.cottonii)、カタメンキリンサ
イ(E.gelatinae)及びアマクサキリンサイ
(E.amakusaensis)、E.dentic
ulatum、E.spinosum、E.alvar
ezii、K.procrusteanum及びK.c
ottonii、K.alvareziiであり、特に
好ましいのは、トゲキリンサイ(E.serra)、ユ
ーキュウマコットニー(E.cottonii)、カタ
メンキリンサイ(E.gelatinae)及びアマク
サキリンサイ(E.amakusaensis)であ
る。
[0006] The protein containing the lectin of the genus Giraffe is a genus of the genus Giraffe (Euchema or Kappa).
aphycus), and as the seaweeds belonging to the genus Kirinsai, there are E. serra and Eucumacotney (E. c).
o. totonii), E. gela
tinae) and E. amakurinsai (E.
saensis), E.C. denticulatum,
E. FIG. muricatum, E.C. cupresoiseu
m, E.C. spinosum, E .; arnoldii,
E. FIG. alvarezii, E. et al. E such as stratum
ucheuma and K. procrusteanu
m, K. cottonii, K .; striatum,
K. alvarezii, K. et al. arnoldii et al.
Seaweed belonging to the genus appaphycus is exemplified. Judging from the lectin content and availability, etc., it is preferable to use E. serra, E. cottonii, E. gelatinae, and E. akumasaensis. , E .; dentic
uratum, E .; spinosum, E .; alvar
ezii, K .; procrusteanum and K. et al. c
ottonii, K .; alvarezii, particularly preferred are E. serra, E. cottonii, E. gelatinae and E. amakusaensis.

【0007】上記キリンサイ属レクチンを含むタンパク
質としては、上記キリンサイ属に属する海藻を原料と
し、緩衝液及び溶媒−水混合液から選ばれる抽出溶媒で
抽出後、この抽出液から溶媒沈殿、透析処理したレクチ
ンを含むタンパク質を粗精製レクチンとして配合するこ
とができる。またこの粗精製レクチンをゲル濾過により
分離精製、更に必要によりイオン交換クロマトグラフィ
ーにより分画した精製レクチンとして配合することがで
きる。
[0007] As the protein containing the genus Kirinsai lectin, seaweed belonging to the genus Kirinsai is used as a raw material, extracted with an extraction solvent selected from a buffer solution and a solvent-water mixture, and then subjected to solvent precipitation and dialysis from the extract. Lectin-containing proteins can be formulated as crude lectins. The crude lectin can be blended as a purified lectin separated and purified by gel filtration and, if necessary, fractionated by ion exchange chromatography.

【0008】この場合、キリンサイ属レクチンとして
は、下記(a)〜(c)のうち少なくとも一つの性状を
有し、かつ下記(d)〜(g)の性状を有するものを用
いることが好ましい。 (a)ゲル濾過法による分子量が約25,000であ
る。 (b)SDS電気泳動法による分子量が約29,000
である。 (c)等電点がポリアクリルアミドゲル等電点電気泳動
法にて測定される場合に、pI4.5〜pI5.7の範
囲、好ましくは、当該ポリアクリルアミドゲル等電点電
気泳動法にてpI4.75、pI4.95、pI5.0
5、pI5.20及びpI5.50から選ばれる少なく
とも一の等電点を示す。 (d)糖鎖を持たない。 (e)N末端領域のアミノ酸配列がGly−Arg−T
yr−Thr−Val−X−Asn−Gln−Trp−
Gly(XはGln或いはLys)である。 (f)トリプシン処理ウサギ赤血球、ヒツジ赤血球及び
トリプシン処理ヒツジ赤血球に対して特異的な凝集活性
を有する。 (g)フェチン、アシアロフェチン、チログロブリン及
びイーストマンナンに対して結合特異性を示す。
In this case, it is preferable to use, as the lectin of the genus Kirinsai, one having at least one of the following properties (a) to (c) and having the following properties (d) to (g). (A) The molecular weight by gel filtration is about 25,000. (B) molecular weight of about 29,000 by SDS electrophoresis
It is. (C) When the isoelectric point is measured by a polyacrylamide gel isoelectric focusing method, it is in the range of pI 4.5 to pI 5.7, preferably pI4 by the polyacrylamide gel isoelectric focusing method. .75, pI 4.95, pI 5.0
5, at least one isoelectric point selected from pI 5.20 and pI 5.50. (D) It has no sugar chain. (E) The amino acid sequence of the N-terminal region is Gly-Arg-T
yr-Thr-Val-X-Asn-Gln-Trp-
Gly (X is Gln or Lys). (F) It has a specific agglutinating activity on trypsin-treated rabbit erythrocytes, sheep erythrocytes and trypsin-treated sheep erythrocytes. (G) Shows binding specificity for fetin, asialofetin, thyroglobulin, and yeast mannan.

【0009】かかるレクチンは、例えばWO95/18
149に記載の方法にて得ることができる。
Such lectins are described, for example, in WO 95/18
149 can be obtained.

【0010】これらのレクチンの配合量は、製品形態や
使用頻度、またその生理活性によっても異なるが、通
常、その一種又は二種以上の混合物を外用剤全体の0.
001〜5重量%の範囲が適当である。
The amount of these lectins varies depending on the form of the product, the frequency of use, and the physiological activity. Usually, one or a mixture of two or more of the lectins is used in a total amount of 0.1% of the total external preparation.
The range of 001 to 5% by weight is appropriate.

【0011】本発明の皮膚外用剤には、上記必須成分の
他に、通常、皮膚外用剤に用いられる配合剤、例えば、
界面活性剤、油分、アルコール類、保湿剤、増粘剤、防
腐剤、酸化防止剤、キレート剤、pH調整剤、香料、色
素、紫外線吸収・散乱剤、ビタミン類、アミノ酸類、水
等を配合することができる。なお、任意成分は、これら
に限定されるものではない。
The external preparation for skin of the present invention includes, in addition to the above-mentioned essential components, compounding agents usually used for external preparation for skin, for example,
Contains surfactants, oils, alcohols, humectants, thickeners, preservatives, antioxidants, chelating agents, pH adjusters, fragrances, pigments, UV absorbers / scatterers, vitamins, amino acids, water, etc. can do. The optional components are not limited to these.

【0012】本発明の皮膚外用剤は、ローション剤、乳
剤、クリーム、軟膏等の形態に調製でき、使用目的に応
じ、例えば化粧料等として適用される。なお、本発明に
おいて、皮膚は頭皮をも包含するものである。
The external preparation for skin of the present invention can be prepared in the form of a lotion, emulsion, cream, ointment and the like, and is applied as a cosmetic according to the purpose of use. In the present invention, the skin includes the scalp.

【0013】[0013]

【実施例】以下、本発明を実施例に基づいて更に詳細に
説明する。ただし、本発明は以下の実施例に制限される
ものではない。なお、実施例及び比較例における皮膚外
用剤の組成は重量%で示す。また、各例の組成におい
て、全成分の合計量は100%である。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in more detail with reference to embodiments. However, the present invention is not limited to the following examples. The compositions of the skin external preparations in Examples and Comparative Examples are shown by weight%. In the composition of each example, the total amount of all components is 100%.

【0014】〔製造例〕WO95/18149に記載の
レクチン製造法に準じて目的とするレクチンを得た。即
ち、トゲキリンサイ、ユーキュウマコットニー、カタメ
ンキリンサイ、及びアマクサキリンサイを採取し、海水
にて良く洗浄した後、凍結乾燥を行い、粉砕機にて粉砕
し海藻粉末を得た。
[Production Example] The desired lectin was obtained according to the lectin production method described in WO95 / 18149. That is, the horned giraffe, the eucouma cotney, the katamen giraffe and the amasaki giraffe were collected, washed well with seawater, freeze-dried, and pulverized with a pulverizer to obtain a seaweed powder.

【0015】それぞれの海藻粉末に10倍量の20〜2
5%のエタノール水溶液を加え、低温下で2回抽出し、
レクチンを含む抽出液を得た。次に、これら抽出液から
レクチンを回収するために、抽出液に冷エタノールを最
終濃度80%以上となるように適量加え、レクチンを含
むタンパク質を沈殿として析出させた。得られた沈殿物
を50mMのリン酸緩衝液(pH7.2)に懸濁し、同
緩衝液に対して透析を行ってエタノールを除去し、各々
のレクチン粗製液を得た。
Each seaweed powder has a 10-fold amount of 20 to 2
Add a 5% aqueous ethanol solution and extract twice at low temperature.
An extract containing lectin was obtained. Next, in order to recover lectins from these extracts, an appropriate amount of cold ethanol was added to the extracts to a final concentration of 80% or more, and proteins containing lectins were precipitated as precipitates. The obtained precipitate was suspended in a 50 mM phosphate buffer (pH 7.2), and the buffer was dialyzed to remove ethanol to obtain crude lectin solutions.

【0016】次いで、レクチン粗製液をゲル濾過クロマ
トグラフィーに供し、トゲキリンサイ由来粗製液からレ
クチンES0、ユーキュウマコットニー由来粗製液から
レクチンEC0、カタメンキリンサイ粗製液からレクチ
ンEG0、アマクサキリンサイ由来粗製液からレクチン
EA0をそれぞれ精製した。
Next, the crude lectin solution was subjected to gel filtration chromatography, and lectin ES0 was obtained from the crude solution derived from the rhododendron rhizome, lectin EC0 was obtained from the crude solution derived from Eucoma cotney, lectin EG0 was obtained from the crude solution derived from the rhododendron rhinoceros, and the crude solution was derived from the crude solution derived from the rhododendron. Lectin EA0 was each purified.

【0017】更に、上記精製レクチンをDEAEイオン
交換クロマトグラフィーに供し、トゲキリンサイ由来の
レクチンES0からES1とES2の2画分を、ユーキ
ュウマコットニー由来のレクチンEC0からEC1とE
C2の2画分を、カタメンキリンサイ由来のレクチンE
G0からEG1、EG2、及びEG3の3画分を、更に
アマクサキリンサイ由来のレクチンEA0からEA1、
EA2、及びEA3の3画分を得た。
Further, the purified lectin was subjected to DEAE ion-exchange chromatography, and two fractions of lectins ES0 to ES1 and ES2 derived from Rhododendron were extracted from lectins EC0 to EC1 and EC1 derived from Eucoma cotney.
Two fractions of C2 were used as the lectin E derived from
The three fractions of G0 to EG1, EG2 and EG3 were further divided into lectins EA0 to EA1 from A.
Three fractions, EA2 and EA3, were obtained.

【0018】以上の方法により得られたレクチンは、出
発原料となる海藻の種類に拘らず、以下の(a)〜
(g)の特徴を有した。 (a)ゲル濾過法による分子量測定で分子量約25,0
00又は(b)SDS電気泳動法による分子量測定で分
子量約29,000又は(c)等電点電気泳動法にて、
pI4.5〜pI5.7の範囲にある1又は2以上の等
電点を示し、かつ、(d)糖鎖を持たず、(e)N末端
領域のアミノ酸配列が、Gly−Arg−Tyr−Th
r−Val−X−Asn−Gln−Trp−Gly(X
はGlnあるいはLys)であり、(f)トリプシン処
理ウサギ赤血球、ヒツジ赤血球及びトリプシン処理ヒツ
ジ赤血球に対して特異的な凝集活性を有し、(g)フェ
チン、アシアロフェチン、チログロブリン及びイースト
マンナンに対して結合特異性を示す。
The lectin obtained by the above method has the following (a) to (4) regardless of the type of seaweed used as a starting material.
(G). (A) A molecular weight of about 25.0 as determined by gel filtration
00 or (b) a molecular weight of about 29,000 as measured by SDS electrophoresis or (c) an isoelectric focusing method,
shows one or more isoelectric points in the range of pI4.5 to pI5.7, (d) has no sugar chain, and (e) the amino acid sequence of the N-terminal region is Gly-Arg-Tyr- Th
r-Val-X-Asn-Gln-Trp-Gly (X
Is Gln or Lys), (f) has a specific agglutinating activity on trypsin-treated rabbit erythrocytes, sheep erythrocytes and trypsin-treated sheep erythrocytes, and (g) has a function on fetin, asialofetin, thyroglobulin and yeast mannan. The binding specificity is shown.

【0019】なお、ポリアクリルアミドゲル等電点電気
泳動法による等電点測定の結果、下記表1に示す等電点
を有することが認められた。
As a result of isoelectric point measurement by polyacrylamide gel isoelectric point electrophoresis, it was confirmed that it has an isoelectric point shown in Table 1 below.

【0020】[0020]

【表1】 [Table 1]

【0021】更に、各々レクチンは、それぞれマウス及
びヒトリンパ球に対して、幼若化活性を有することが確
認された。
Further, it was confirmed that each lectin has blastogenic activity on mouse and human lymphocytes, respectively.

【0022】下記例においては、上記に示したようにト
ゲキリンサイ、ユーキュウマコットニー、カタメンキリ
ンサイ、及びアマクサキリンサイの海藻粉末から、20
〜25%のエタノール水溶液で抽出し、抽出液に冷エタ
ノールを最終濃度80%以上となるように加え、レクチ
ンを含むタンパク質を沈殿として析出させ、得られた沈
殿物を純水にて透析したものを粗精製レクチンとして用
いた。
In the following examples, as shown above, 20 powders of the seaweed powders of the rhododendron, the eucouma cotney, the phalaenopsis and the
Extracted with ~ 25% ethanol aqueous solution, added cold ethanol to the extract to a final concentration of 80% or more, precipitated lectin-containing protein as a precipitate, and dialyzed the obtained precipitate against pure water Was used as a crude lectin.

【0023】また、下記例において、荒れ肌改善及び皮
膚保湿効果については、以下の方法で調べた。男女パネ
ラー30人の前腕内側部をアセトン:エーテル=1:1
の混合溶媒で脱脂し、荒れ肌を作成した。その後、試料
をそれぞれ1日2回塗布し、3日後に以下の2つの評価
を行った。 (1)荒れ肌改善効果;表面形状観察評価 直接目視及びレプリカ法により荒れ肌の症状の観察を行
った。なお、ここでいう荒れ肌の症状とは、角層剥離,
紅斑,浮腫が起きる、皮溝,皮丘がはっきりせず肌のキ
メがそろわない等を示す。
In the following examples, the effects of improving rough skin and moisturizing the skin were examined by the following methods. Acetone: ether = 1: 1 for the inner forearm of 30 male and female panelists
The mixture was degreased with a mixed solvent to prepare rough skin. Thereafter, each sample was applied twice a day, and three days later, the following two evaluations were performed. (1) Improvement effect of rough skin; evaluation of surface shape observation The symptoms of rough skin were observed by direct visual observation and replica method. The symptoms of rough skin referred to here are horny layer peeling,
It shows erythema and edema, skin sulcus and skin ridges are not clear, and skin texture is not uniform.

【0024】荒れ肌改善効果は以下の基準で評点を付
け、評価を行った。 (評点) 著 効:荒れ肌の症状が消失した 有 効:荒れ肌の症状が弱くなった やや有効:荒れ肌の症状がやや弱くなった 無 効:荒れ肌の症状に変化が見られない (評価) ◎:著効、有効、及びやや有効の評価をした被験者が8
0%以上 ○:著効、有効、及びやや有効の評価をした被験者が5
0%以上80%未満 △:著効、有効、及びやや有効の評価をした被験者が3
0%以上50%未満 ×:著効、有効、及びやや有効の評価をした被験者が3
0%未満
The rough skin improving effect was rated and evaluated according to the following criteria. (Score) Excellent Efficacy: The symptoms of rough skin disappeared. Efficacy: The symptoms of rough skin weakened. Eight subjects who evaluated significant, effective, and somewhat effective
0% or more ○: 5 subjects who evaluated excellent, effective, and somewhat effective
0% or more and less than 80% △: 3 subjects who evaluated excellent, effective and slightly effective
0% or more and less than 50% ×: 3 subjects who evaluated significant, effective and slightly effective
Less than 0%

【0025】(2)皮膚保湿効果;皮表角質水分量測定 評価部位の皮表角質水分量をインピーダンスメーターを
用いて測定した。
(2) Skin moisturizing effect; measurement of skin keratin water content The skin keratin water content at the evaluation site was measured using an impedance meter.

【0026】皮膚保湿効果は、以下の基準で評点を付
け、評価を行った。なお、ここでいう基剤とは、レクチ
ン及び比較成分のいずれも含まないクリームである。 (評点) 著 効:基剤塗布部位と比べて測定値が200%以上 有 効:基剤塗布部位と比べて測定値が150%以上
200%未満 やや有効:基剤塗布部位と比べて測定値が110%以上
150%未満 無 効:基剤塗布部位と比べて測定値が110%未満 (評価) ◎:著効、有効、及びやや有効の評価をした被験者が8
0%以上 ○:著効、有効、及びやや有効の評価をした被験者が5
0%以上80%未満 △:著効、有効、及びやや有効の評価をした被験者が3
0%以上50%未満 ×:著効、有効、及びやや有効の評価をした被験者が3
0%未満
The skin moisturizing effect was rated and evaluated according to the following criteria. Here, the base is a cream containing neither lectin nor comparative components. (Score) Excellent: The measured value is 200% or more compared to the base application site. Effective: The measured value is 150% or more and less than 200% compared to the base application site. Is 110% or more and less than 150% Ineffective: The measured value is less than 110% as compared with the base application site (Evaluation) :: 8 subjects who evaluated excellent, effective, and slightly effective
0% or more ○: 5 subjects who evaluated excellent, effective, and somewhat effective
0% or more and less than 80% △: 3 subjects who evaluated excellent, effective and slightly effective
0% or more and less than 50% ×: 3 subjects who evaluated significant, effective and slightly effective
Less than 0%

【0027】更に、皮膚の老化防止・改善効果について
は、以下の方法で調べた。 (3)皮膚の老化防止・改善効果の評価 男女パネラー70人(35〜60歳)を1群10名と
し、各群の顔面に1日3回、試料をブラインドにて連続
3ヶ月間使用させた。評価終了後、パネラー本人が皮膚
の状態を、「小じわの改善効果」、「肌のきめに対する
効果」、「つや・はりに対する効果」についてそれぞれ
「改善」、「やや改善」、「変化なし」の3段階で評価
した。
Further, the effect of preventing and improving skin aging was examined by the following method. (3) Evaluation of skin aging prevention / improvement effect 70 male and female panelists (35 to 60 years old) were grouped into 10 persons, and the face of each group was used three times a day blindly for three consecutive months. Was. After the evaluation was completed, the panelists evaluated the skin condition as “improved”, “slightly improved”, and “no change” for “effects on fine wrinkles”, “effect on skin texture”, and “effect on gloss and beam”, respectively. The evaluation was made in three stages.

【0028】〔実施例1〜20、比較例1〜5〕表2,
3に示す組成のクリームを製造した。製造法は、油分、
活性剤からなる油相、精製水などからなる水相をそれぞ
れ70℃で混合溶解し、水相を撹拌しながら油相を徐々
に添加し予備乳化を行った。この後、乳化機(ホモミキ
サー)処理を行い、乳化粒子を均一にし、脱気、冷却
後、室温にてキリンサイ由来レクチンを添加、分散させ
仕上げた。
Examples 1 to 20, Comparative Examples 1 to 5
A cream having the composition shown in No. 3 was produced. The production method is oil,
An oil phase composed of an activator and an aqueous phase composed of purified water were mixed and dissolved at 70 ° C. respectively, and the oil phase was gradually added while stirring the aqueous phase to carry out preliminary emulsification. Thereafter, an emulsifier (homomixer) treatment was performed to homogenize the emulsified particles, and after degassing and cooling, lectins derived from Kirinsai were added and dispersed at room temperature to finish.

【0029】ここで荒れ肌改善効果、保湿改善効果につ
いて、上記(1)、(2)の試験によって評価した。
Here, the effects of improving rough skin and improving moisture retention were evaluated by the tests (1) and (2) described above.

【0030】[0030]

【表2】 [Table 2]

【0031】[0031]

【表3】 [Table 3]

【0032】〔実施例21〜26、比較例6〕表4に示
す組成のクリームを製造した。製造法は、油分、活性剤
からなる油相、精製水などからなる水相をそれぞれ70
℃で混合溶解し、水相を撹拌しながら油相を徐々に添加
し予備乳化を行った。この後、乳化機(ホモミキサー)
処理を行い、乳化粒子を均一にし、脱気、冷却後、室温
にてキリンサイ由来レクチンを添加、分散させ仕上げ
た。
Examples 21 to 26, Comparative Example 6 Creams having the compositions shown in Table 4 were produced. The production method is to convert an oil phase, an oil phase composed of an activator, and an aqueous phase composed of purified water into 70 parts each.
The mixture was dissolved at a temperature of ° C., and the oil phase was gradually added while stirring the aqueous phase to carry out preliminary emulsification. After this, an emulsifier (homomixer)
After the treatment, the emulsified particles were made uniform, and after degassing and cooling, lectins derived from Kirinsai were added and dispersed at room temperature to finish.

【0033】ここで皮膚の老化防止・改善効果につい
て、上記(3)の試験によって評価した。結果は表4に
おいて各評価を示したパネラー数にて示した。
Here, the effect of preventing and improving aging of the skin was evaluated by the test of the above (3). The results are shown in Table 4 by the number of panelists indicating each evaluation.

【0034】[0034]

【表4】 [Table 4]

【0035】以下、更に処方例を示す。Hereinafter, examples of the formulation will be further described.

【0036】[0036]

【表5】 [Table 5]

【0037】[0037]

【表6】 [Table 6]

【0038】[0038]

【表7】 [Table 7]

【0039】[0039]

【表8】 [Table 8]

【0040】[0040]

【表9】 [Table 9]

【0041】[0041]

【表10】 [Table 10]

【0042】[0042]

【表11】 [Table 11]

【0043】[0043]

【表12】 [Table 12]

【0044】[0044]

【表13】 [Table 13]

【0045】[0045]

【表14】 [Table 14]

【0046】[0046]

【表15】 [Table 15]

【0047】[0047]

【表16】 [Table 16]

【0048】[0048]

【表17】 [Table 17]

【0049】[0049]

【表18】 [Table 18]

【0050】[0050]

【表19】 [Table 19]

【0051】[0051]

【表20】 [Table 20]

【0052】[0052]

【表21】 [Table 21]

【0053】[0053]

【表22】 [Table 22]

【0054】[0054]

【表23】 [Table 23]

【0055】[0055]

【発明の効果】本発明の皮膚外用剤は、荒れ肌改善、皮
膚保湿効果及び皮膚の老化防止・改善効果に優れたもの
である。
The external preparation for skin of the present invention is excellent in improving rough skin, moisturizing skin, and preventing and improving skin aging.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 38/36 AGZ A61K 37/46 AGZ ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 38/36 AGZ A61K 37/46 AGZ

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 キリンサイ属レクチンを含むタンパク質
を含有する皮膚外用剤。
1. An external preparation for skin containing a protein containing a ginseng lectin.
【請求項2】 キリンサイ属レクチンが、下記(a)〜
(c)のうち少なくとも一つの性状を有し、かつ下記
(d)〜(g)の性状を有するものである請求項1記載
の皮膚外用剤。 (a)ゲル濾過法による分子量が約25,000であ
る。 (b)SDS電気泳動法による分子量が約29,000
である。 (c)等電点電気泳動法による等電点がpI4.5〜p
I5.7の範囲にある。(d)糖鎖を持たない。 (e)N末端領域のアミノ酸配列がGly−Arg−T
yr−Thr−Val−X−Asn−Gln−Trp−
Gly(XはGln或いはLys)である。 (f)トリプシン処理ウサギ赤血球、ヒツジ赤血球及び
トリプシン処理ヒツジ赤血球に対して特異的な凝集活性
を有する。 (g)フェチン、アシアロフェチン、チログロブリン及
びイーストマンナンに対して結合特異性を示す。
2. The ginseng lectin according to the following (a)-
2. The external preparation for skin according to claim 1, which has at least one property of (c) and has the following properties (d) to (g). (A) The molecular weight by gel filtration is about 25,000. (B) molecular weight of about 29,000 by SDS electrophoresis
It is. (C) The isoelectric point obtained by isoelectric focusing is pI 4.5 to pI.
I5.7. (D) It has no sugar chain. (E) The amino acid sequence of the N-terminal region is Gly-Arg-T
yr-Thr-Val-X-Asn-Gln-Trp-
Gly (X is Gln or Lys). (F) It has a specific agglutinating activity on trypsin-treated rabbit erythrocytes, sheep erythrocytes and trypsin-treated sheep erythrocytes. (G) Shows binding specificity for fetin, asialofetin, thyroglobulin, and yeast mannan.
JP10100610A 1998-03-27 1998-03-27 Skin preparation for external use Pending JPH11279072A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10100610A JPH11279072A (en) 1998-03-27 1998-03-27 Skin preparation for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10100610A JPH11279072A (en) 1998-03-27 1998-03-27 Skin preparation for external use

Publications (1)

Publication Number Publication Date
JPH11279072A true JPH11279072A (en) 1999-10-12

Family

ID=14278623

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10100610A Pending JPH11279072A (en) 1998-03-27 1998-03-27 Skin preparation for external use

Country Status (1)

Country Link
JP (1) JPH11279072A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002193737A (en) * 2000-12-28 2002-07-10 Kose Corp Skin care preparation for external use and skin care composition for external use
JP2005089390A (en) * 2003-09-19 2005-04-07 Kanebo Cosmetics Inc Cosmetic
JP2010229107A (en) * 2009-03-27 2010-10-14 Kose Corp Cosmetic composition, and skin external preparation or cosmetic which contain the same
JP2010248170A (en) * 2009-03-27 2010-11-04 Kose Corp Cosmetic composition and skin care agent for external use or cosmetic containing the cosmetic composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002193737A (en) * 2000-12-28 2002-07-10 Kose Corp Skin care preparation for external use and skin care composition for external use
JP4597362B2 (en) * 2000-12-28 2010-12-15 株式会社コーセー Skin external preparation and skin external preparation composition
JP2005089390A (en) * 2003-09-19 2005-04-07 Kanebo Cosmetics Inc Cosmetic
JP2010229107A (en) * 2009-03-27 2010-10-14 Kose Corp Cosmetic composition, and skin external preparation or cosmetic which contain the same
JP2010248170A (en) * 2009-03-27 2010-11-04 Kose Corp Cosmetic composition and skin care agent for external use or cosmetic containing the cosmetic composition

Similar Documents

Publication Publication Date Title
KR101480700B1 (en) Composition for skin external application containing complex of herbal extracts
JP2597084B2 (en) Cosmetic composition
JPH09143087A (en) Skin preparation for external use
CN111526864A (en) Cosmetic use of protein extracts of moringa seeds
JPS59134706A (en) Cosmetic
JPH0873342A (en) Skin external preparation or bathing agent containing rubi fructus extract
JP3722511B2 (en) Skin preparations and bath preparations
JPS6219511A (en) Cosmetic for preventing aging of skin
JP3172753B2 (en) Biological hyaluronic acid synthesis promoter
JPH10158181A (en) Lipolysis promoter and skin cosmetic for weight reduction
JPH11279072A (en) Skin preparation for external use
JPH10194947A (en) Cosmetic composition containing extract of plant of family cannabaceae
JP2001288068A (en) Skin cosmetic
KR101853927B1 (en) A cosmetic composition comprising enzymatic hydrolysate of salmon scaled with the excellent effect of skin exfoliation efficacy, itching improvement and scalp dandruff improvemtny
JPH01117815A (en) External preparation for skin
JP2003160497A (en) Skin care preparation
KR20220163294A (en) A cosmetic composition mimicking placenta
JP2006117607A (en) Skin care preparation
JPH0820522A (en) Keratinizing anzyme activity promoter and cosmetic containing the same
CN116322637A (en) Novel use of peptides for improving skin and/or mucous membrane comfort and/or integument appearance
JP2000212058A (en) Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor
JPH05294819A (en) Beautifying cosmetic
JPS62149629A (en) Humectant skin agent
JPS6277308A (en) Cosmetic
JPS60252405A (en) Cosmetic